Central Venous Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Central Venous Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Central Venous Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Central Venous Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A central venous catheter is a long, thin, flexible tube used to administer medicines, fluids, nutrients, or blood products and to monitor haemodynamic status of the patients in surgical and critical care settings over a long period of time, usually several weeks or more.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Central Venous Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Central Venous Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Central Venous Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Central Venous Catheters Overview
4 Products under Development
4.1 Central Venous Catheters - Pipeline Products by Stage of Development
4.2 Central Venous Catheters - Pipeline Products by Segment
4.3 Central Venous Catheters - Pipeline Products by Territory
4.4 Central Venous Catheters - Pipeline Products by Regulatory Path
4.5 Central Venous Catheters - Pipeline Products by Estimated Approval Date
5 Central Venous Catheters - Pipeline Products under Development by Companies
5.1 Central Venous Catheters Companies - Pipeline Products by Stage of Development
5.2 Central Venous Catheters – Companies Pipeline Products by Stage of Development
6 Central Venous Catheters Companies and Product Overview
6.1 Acatechol Inc Company Overview
6.1.1 Acatechol Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 Air Force Research Laboratory Company Overview
6.2.1 Air Force Research Laboratory Pipeline Products & Ongoing Clinical Trials Overview
6.3 AngioDynamics Inc Company Overview
6.3.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.4 Ash Access Technology Inc Company Overview
6.4.1 Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
6.5 Bactiguard Holding AB Company Overview
6.5.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview
6.6 Charite University Hospital of Berlin Company Overview
6.6.1 Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview
6.7 CR Bard Inc Company Overview
6.7.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
6.8 DAK Scientific Inc Company Overview
6.8.1 DAK Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
6.9 FreeFlow Medical Devices LLC Company Overview
6.9.1 FreeFlow Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
6.10 Globe Medical Tech Inc (Inactive) Company Overview
6.10.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.11 Lipocoat BV Company Overview
6.11.1 Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview
6.12 LiquiGlide Inc Company Overview
6.12.1 LiquiGlide Inc Pipeline Products & Ongoing Clinical Trials Overview
6.13 Marvao Medical Devices Ltd Company Overview
6.13.1 Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.14 NHC LLC Company Overview
6.14.1 NHC LLC Pipeline Products & Ongoing Clinical Trials Overview
6.15 Protectus Medical Devices, Inc. Company Overview
6.15.1 Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.16 S3V Vascular Technologies Company Overview
6.16.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
6.17 Sharklet Technologies Inc Company Overview
6.17.1 Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.18 Silver Bullet Therapeutics, Inc. Company Overview
6.18.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.19 Tel Aviv University Company Overview
6.19.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
6.20 Terumo Corp Company Overview
6.20.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
6.21 University of Illinois at Chicago Company Overview
6.21.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
6.22 University of Texas Health Science Center at Houston Company Overview
6.22.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview
6.23 University of Washington Company Overview
6.23.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview
6.24 Velano Vascular East Company Overview
6.24.1 Velano Vascular East Pipeline Products & Ongoing Clinical Trials Overview
6.25 Vindica Therapeutics, Inc Company Overview
6.25.1 Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview
7
8 Central Venous Catheters- Recent Developments
8.1 May 16, 2023: PAVmed provides business update and Q1 financial results
8.2 May 05, 2023: PAVmed to hold a business update conference call and webcast on May 17, 2023
8.3 May 04, 2023: Teleflex reports first quarter financial results and full year 2023 outlook
8.4 Apr 20, 2023: Teleflex announces first quarter 2023 earnings conference call information
8.5 Mar 14, 2023: PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2022 Financial Results
8.6 Feb 23, 2023: Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results
8.7 Feb 21, 2023: Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference
8.8 Feb 09, 2023: Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information
8.9 Jan 06, 2023: BD Announces Webcast of Annual Meeting of Shareholders
8.10 Dec 15, 2022: PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform
8.11 Dec 08, 2022: BD Releases 2022 Global Inclusion, Diversity and Equity Annual Report
8.12 Dec 08, 2022: T2 Biosystems highlights peer-reviewed article linking COVID-19 and sepsis and underscoring CDC call for adoption of early and accurate microbial diagnosis to guide targeted initial antimicrobial therapy
8.13 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
8.14 Nov 15, 2022: PAVmed Provides Business Update and Third Quarter 2022 Financial Results
8.15 Nov 04, 2022: Poly Medicure Announces Unaudited Standalone & Consolidated Financial Results for the Quarter Ended 0n 30th Sep. 2022
8.16 Oct 27, 2022: Teleflex Reports Third Quarter Financial Results And Full Year Outlook
8.17 Oct 13, 2022: Teleflex Announces Third Quarter 2022 Earnings Conference Call Information
8.18 Sep 15, 2022: Lifecome Biochemistry Co. Announces resignation of the company's directors
8.19 Aug 24, 2022: BD to Present at the Wells Fargo 2022 Healthcare Conference
8.20 Aug 16, 2022: Pavmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results
8.21 Aug 15, 2022: Retractable Technologies Announces Results for the Periods Ended June 30, 2022
8.22 Aug 04, 2022: Poly Medicure announces Financial results For The Quarter Ended 30Th June 2022
9 Appendix
9.1 Methodology
9.2 About GlobalData
9.3 Contact Us
9.4 Disclaimer
2.1 List of Tables
Table 1: Central Venous Catheters - Pipeline Products by Stage of Development
Table 2: Central Venous Catheters - Pipeline Products by Segment
Table 3: Central Venous Catheters - Pipeline Products by Territory
Table 4: Central Venous Catheters - Pipeline Products by Regulatory Path
Table 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date
Table 6: Central Venous Catheters Companies - Pipeline Products by Stage of Development
Table 7: Central Venous Catheters – Companies Pipeline Products by Stage of Development
Table 8: Acatechol Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Antimicrobial Central Venous Catheter - Product Status
Table 10: Antimicrobial Central Venous Catheter - Product Description
Table 11: Air Force Research Laboratory Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Pulsing Frontline Trace Catheter - Product Status
Table 13: Pulsing Frontline Trace Catheter - Product Description
Table 14: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: BioFlo PICC Line Extension - Product Status
Table 16: BioFlo PICC Line Extension - Product Description
Table 17: Next Generation BioFlo PICC - Product Status
Table 18: Next Generation BioFlo PICC - Product Description
Table 19: Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: BaxCath Impregnation System - Product Status
Table 21: BaxCath Impregnation System - Product Description
Table 22: Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Transvascular Injection Catheter - Product Status
Table 24: Transvascular Injection Catheter - Product Description
Table 25: Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Central Venous Permanent Catheter - Product Status
Table 27: Central Venous Permanent Catheter - Product Description
Table 28: CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Anti-Thrombotic PICC - Product Status
Table 30: Anti-Thrombotic PICC - Product Description
Table 31: Antimicrobial PICC - Product Status
Table 32: Antimicrobial PICC - Product Description
Table 33: COVERT PowerPICC - Product Status
Table 34: COVERT PowerPICC - Product Description
Table 35: DAK Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: PICC Line - Product Status
Table 37: PICC Line - Product Description
Table 38: FreeFlow Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 39: TLP-Coated PICC Catheter - Product Status
Table 40: TLP-Coated PICC Catheter - Product Description
Table 41: Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Safety IV Catheter - Product Status
Table 43: Safety IV Catheter - Product Description
Table 44: Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Coated CVC Catheter - Product Status
Table 46: Coated CVC Catheter - Product Description
Table 47: LiquiGlide Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: LIS-Coated PICC - Product Status
Table 49: LIS-Coated PICC - Product Description
Table 50: Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 51: NexSite 8Fr Single Lumen Central Venous Catheter - Product Status
Table 52: NexSite 8Fr Single Lumen Central Venous Catheter - Product Description
Table 53: NHC LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Otricath - Product Status
Table 55: Otricath - Product Description
Table 56: Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Safety IV Catheter - Product Status(Protectus Medical Devices, inc.)
Table 58: Safety IV Catheter - Product Description(Protectus Medical Devices, Inc.)
Table 59: S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
Table 60: 3V AGILE - Product Status
Table 61: 3V AGILE - Product Description
Table 62: Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Sharklet Central Venous Catheter - Product Status
Table 64: Sharklet Central Venous Catheter - Product Description
Table 65: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Cathanic Venous Catheter - Product Status
Table 67: Cathanic Venous Catheter - Product Description
Table 68: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Short Peripheral Infusion Catheter - Product Status
Table 70: Short Peripheral Infusion Catheter - Product Description
Table 71: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 72: TERUMO Surshield-PUR Safety I.V. Catheter - Product Status
Table 73: TERUMO Surshield-PUR Safety I.V. Catheter - Product Description
Table 74: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Extendable Intravenous Catheter - Product Status
Table 76: Extendable Intravenous Catheter - Product Description
Table 77: University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Automated Catheter Insertion System - Product Status
Table 79: Automated Catheter Insertion System - Product Description
Table 80: University of Washington Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Advanced Medical Catheter - Product Status
Table 82: Advanced Medical Catheter - Product Description
Table 83: Velano Vascular East Pipeline Products & Ongoing Clinical Trials Overview
Table 84: China Midline Catheter - Product Status
Table 85: China Midline Catheter - Product Description
Table 86: Next Gen Central Catheter - Product Status
Table 87: Next Gen Central Catheter - Product Description
Table 88: Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Status
Table 90: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Description
Table 91: Glossary
2.2 List of Figures
Figure 1: Central Venous Catheters - Pipeline Products by Stage of Development
Figure 2: Central Venous Catheters - Pipeline Products by Segment
Figure 3: Central Venous Catheters - Pipeline Products by Territory
Figure 4: Central Venous Catheters - Pipeline Products by Regulatory Path
Figure 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings